Cargando…
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticul...
Autores principales: | Masciarelli, S, Capuano, E, Ottone, T, Divona, M, De Panfilis, S, Banella, C, Noguera, N I, Picardi, A, Fontemaggi, G, Blandino, G, Lo-Coco, F, Fazi, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808088/ https://www.ncbi.nlm.nih.gov/pubmed/28776567 http://dx.doi.org/10.1038/leu.2017.231 |
Ejemplares similares
-
PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells
por: Banella, Cristina, et al.
Publicado: (2019) -
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
por: Noguera, N. I., et al.
Publicado: (2019) -
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017) -
All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis
por: Colvin, Teresa A., et al.
Publicado: (2018) -
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
Publicado: (2017)